Discover

MASS
908 Devices Inc.
8.88
2 x 6.37
2 x 11.05
bid
ask
+
0.18
2.07%
2 @ 04:00 PM
8.89 +0.01 (0.11%)
Ytd69.14%
1y37.04%
8.56
day range
8.96
5.03
52 week range
9.34
Open8.64Prev Close8.70Low8.56High8.96Mkt Cap335.78M
Vol245.83KAvg Vol294.44KEPS-0.97P/EN/AForward P/E-1.78
Beta0.98Short Ratio3.57Inst. Own69.75%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0450-d Avg7.87200-d Avg7.011yr Est5.67
Earning
DateForEstimateReportedSurprisesurprise %
2024-11-122024-09-0.29-0.230.0620.69%
2024-08-062024-06-0.34-0.320.025.88%
2024-08-062024-06-0.34N/AN/AN/A
2024-04-302024-03-0.37-0.330.0410.81%
2024-04-302024-03-0.37N/AN/AN/A
2024-03-052023-12-0.27N/AN/AN/A
Upgrade / Downgrade
DateFirmActionFromTo
2024-11-13StifelUpgradeBuyBuy
2024-11-13Leerink PartnersDowngradeOutperformMarket Perform
2024-10-17Leerink PartnersUpgradeOutperformOutperform
2024-05-13Stephens & Co.UpgradeOverweightOverweight
2023-09-25Stephens & Co.UpgradeOverweightOverweight
2023-02-07Stephens & Co.UpgradeOverweight
Profile
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Insider Holder
DateNameRelationQuantityDescription
2024-12-18BROWN CHRISTOPHER DOfficer946.45KConversion of Exercise of derivative security
2024-06-11CRANDELL KEITH L.Director and Beneficial Owner of more than 10% of a Class of Security5.74MConversion of Exercise of derivative security
2024-06-11EISENBERG MARCIADirector14.59KConversion of Exercise of derivative security
2024-06-11ELOI FENEL MDirector15.45KConversion of Exercise of derivative security
2024-06-11GEORGE JEFFREY P.Director15.45KConversion of Exercise of derivative security
2024-03-25GRIFFITH JOSEPH H. IVChief Financial Officer93.44KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2024-09-29ARK Investment Management, LLC3.22M6.12M9.25%
2024-09-29Blackrock Inc.1.88M3.58M5.41%
2024-09-29Vanguard Group Inc1.88M3.57M5.39%
2024-09-29Ameriprise Financial, Inc.1.84M3.50M5.29%
2024-09-29AWM Investment Company, Inc.1.57M2.99M4.52%
2024-09-29Granahan Investment Management LLC861.43K1.64M2.47%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2024-10-30ARK ETF Tr-ARK Genomic Revolution ETF3.13M5.94M8.97%
2024-08-30Columbia Fds Ser Tr I-Columbia Small Cap Growth Fd I1.51M2.87M4.33%
2024-09-29Vanguard Total Stock Market Index Fund792.16K1.51M2.27%
2024-10-30iShares Russell 2000 ETF618.82K1.18M1.78%
2024-08-30Vanguard Information Technology Index Fund605.98K1.15M1.74%
2024-07-30Alger Fund-Small Cap Growth Fund444.98K845.46K1.28%